Note 9 —Subsequent Events‌

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than as described below, the Company did not identify any events that would have required adjustments to the disclosures in the financial statements.

‌‌On January 18, 2024, the Company entered into Amendment No. 2 to the Trust Agreement to provide that Continental may maintain the funds in the Trust Account in an interest-bearing bank demand deposit account, and the Company sent an Investment Instruction Letter to Continental, pursuant to which the Company instructed Continental to move the funds in the Trust Account to such a demand deposit account.

On February 6, 2024, the Company, issued a non-convertible unsecured promissory note to the Sponsor, for a collective principal amount of $550,000 (the “February 2024 Promissory Note”). The Sponsor provides these additional funds for working capital purposes and to support future extension payments by the Company to extend the Combination Period on a monthly basis up to July 23, 2024, as set forth in the Company’s Memorandum and Articles. The February 2024 Promissory Note bears no interest and is repayable in full upon the consummation of a business combination by the Company. On February 1, 2024 and February 7, 2024, the Company received $97,899 and

$452,100 respectively, under the February 2024 Promissory Note. Up to the date the financial statements were issued, the outstanding balance under the February 2024 Promissory Note was $549,999.

On January 19, 2024, February 21, 2024 and March 21, 2024, the Company deposited total of $375,000 into Trust Account to extend the date by which the Company must consummate an initial Business Combination to April 23, 2024.

On March 28, 2024, the Company filed Form 25 with the SEC informing the SEC and the NYSE of the delisting of the Company’s securities from the NYSE, which form becomes effective within 10 days of filing. Concurrently, the Company filed new Form 8-A with the SEC with respect to its Class A Ordinary Shares which have been approved for listing on the Nasdaq Global Market (“Nasdaq”) with the first trading day on April 8, 2024. The Units and warrants to purchase Class A Ordinary Shares will continue trading over-the-counter.

On March 29, 2024, the Company filed a Form 14A with the SEC, announcing that an extraordinary general meeting will be held on April 16, 2024 to vote on the extension amendment proposal, the trust amendment proposal and the adjournment proposal as disclosed in Form 14A.